Proteomics

Dataset Information

0

Systematic Proteome Profiling of Maternal Plasma for Development of Preeclampsia Biomarkers


ABSTRACT: Background: Preeclampsia (PE) is a hypertensive disorder of pregnancy with various clinical symptoms. However, traditional markers for the disease including high blood pressure and proteinuria are poor indicators of the related adverse outcomes. Here, we performed systematic proteome profiling of plasma samples obtained from pregnant women with PE to identify clinically effective diagnostic biomarkers. Methods: Proteome profiling was performed using TMT-based liquid chromatography-mass spectrometry (LC-MS/MS) followed by subsequent verification by multiple reaction monitoring (MRM) analysis on normal and PE maternal plasma samples. Functional annotations of differentially expressed proteins (DEPs) in PE were predicted using bioinformatic tools. The diagnostic accuracies of the biomarkers for PE were estimated according to the area under the receiver operating characteristics curve (AUC). Results: A total of 1,307 proteins were identified, and 870 proteins of them were quantified from plasma samples. Significant differences were evident in 138 DEPs, including 71 upregulated DEPs and 67 downregulated DEPs in the PE group, compared with those in the control group. Up-regulated proteins were significantly associated with biological processes including platelet degranulation, proteolysis, lipoprotein metabolism, and cholesterol efflux. Biological processes including blood coagulation and acute-phase response were enriched for down-regulated proteins. Of these, 40 proteins were subsequently validated in an independent cohort of 26 PE patients and 29 healthy controls. APOM, LCN2, and QSOX1 showed high diagnostic accuracies for PE detection (AUC > 0.9 and P < 0.001, for all) as validated by MRM and ELISA. Conclusions: Our data demonstrate that three plasma biomarkers, identified by systematic proteomic profiling, present a possibility for the assessment of PE, independent of the clinical characteristics of pregnant women.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Plasma

SUBMITTER: Jaemin Lim  

LAB HEAD: Kwang Pyo Kim

PROVIDER: PXD050118 | Pride | 2025-05-06

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
20180614_PE_Plasma_SET1_F1.raw Raw
20180614_PE_Plasma_SET1_F10.raw Raw
20180614_PE_Plasma_SET1_F11.raw Raw
20180614_PE_Plasma_SET1_F12.raw Raw
20180614_PE_Plasma_SET1_F2.raw Raw
Items per page:
1 - 5 of 56
altmetric image

Publications

Systematic Proteome Profiling of Maternal Plasma for Development of Preeclampsia Biomarkers.

Lim Ji Hyae JH   Lim Jae Min JM   Lee Hyeong Min HM   Lee Hyun Jung HJ   Kwak Dong Wook DW   Han You Jung YJ   Kim Moon Young MY   Jung Sang Hee SH   Kim Young Ran YR   Ryu Hyun Mee HM   Kim Kwang Pyo KP  

Molecular & cellular proteomics : MCP 20240805 9


Preeclampsia (PE) is a hypertensive disorder of pregnancy with various clinical symptoms. However, traditional markers for the disease including high blood pressure and proteinuria are poor indicators of the related adverse outcomes. Here, we performed systematic proteome profiling of plasma samples obtained from pregnant women with PE to identify clinically effective diagnostic biomarkers. Proteome profiling was performed using TMT-based liquid chromatography-mass spectrometry (LC-MS/MS) follow  ...[more]

Similar Datasets

2023-03-11 | PXD037267 | Pride
2024-01-25 | PXD032981 | Pride
2025-03-11 | PXD061698 | Pride
2022-10-14 | PXD035884 | Pride
2024-09-17 | PXD052260 | Pride
2018-11-21 | PXD009025 | Pride
2024-12-20 | PXD042941 | Pride
2021-09-09 | PXD020117 | Pride
2012-09-18 | E-GEOD-37957 | biostudies-arrayexpress
2018-07-05 | PXD003419 | Pride